The Cost of Swiggy’s Growth; Taking the Pain Out of Healthcare

Swiggy's quick commerce expansion is driving its top-line growth but at a rising expansion cost. In recent quarterly figures, Swiggy reported that losses nearly doubled in Q4, driven by heavy spends in its Instamart quick commerce business and higher promotion expenditure. Consolidated top-line growth jumped sharply-expected to rise 26% year-on-year to ₹4,227 crore-losses are likely to expand to up to ₹1,031 crore. The company's approach of spending on customer acquisition and scaling the delivery network has led to higher operating expenses, particularly in the Instamart business, and keeping the profitability under constant pressure.

 

Conversely, in the healthtech domain, IntegriMedical is making headlines with its efforts to eliminate risks associated with healthcare delivery in order to make medical services more efficient and safe to access. Both of these concurrent areas of focus-Swiggy's costly scaling in lightning-fast commerce and IntegriMedical's initiatives in healthcare-indicate the changing landscape of Indian startups as they attempt to match the pace of aggressive growth while requiring sustainable business models.

 

Source: YourStory